XML 32 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring Actions
12 Months Ended
Dec. 31, 2022
Restructuring and Related Activities [Abstract]  
Restructuring Actions Restructuring Actions
2020 through 2022 Restructuring Action
Operational/Marketing Capability Restructuring:
In late 2020, 3M announced it would undertake certain actions beginning in the fourth quarter of 2020 to further enhance its operations and marketing capabilities to take advantage of certain global market trends while de-prioritizing investments in slower-growth end markets, resulting in a pre-tax charge of $137 million. In 2021, management approved and committed to undertake additional actions under this initiative resulting in a 2021 pre-tax charge of $124 million. In the first quarter of 2022, management approved and committed to undertake the remaining actions under this initiative resulting in a pre-tax charge of $18 million. This initiative, beginning in 2020 and ending with committed first quarter 2022 actions, impacted approximately 3,100 positions worldwide with a pre-tax charge of approximately $280 million over that period. The related restructuring charges for periods presented were recorded in the income statement as follows:
(Millions)202220212020
Cost of sales$$19$51
Selling, general and administrative expenses128879
Research, development and related expenses6177
Total operating income impact$18$124$137
The business segment operating income impact of these restructuring charges is summarized as follows:
202220212020
(Millions)Employee-RelatedEmployee-RelatedEmployee RelatedAsset-Related and OtherTotal
Safety and Industrial$2$30$36$7$43
Transportation and Electronics424161228
Health Care22123326
Consumer2710111
Corporate and Unallocated842161329
Total Operating Expense$18$124$101$36$137
Restructuring actions, including cash and non-cash impacts, follow:
(Millions)Employee-RelatedAsset-Related and OtherTotal
Expense incurred in the fourth quarter of 2020$101 $36 $137 
Non-cash changes— (36)(36)
Accrued restructuring action balances as of December 31, 2020101 — 101 
Incremental expense incurred in 2021124 — 124 
Cash payments(127)— (127)
Adjustments(11)— (11)
Accrued restructuring action balance as of December 31, 202187  87 
Incremental expense incurred in the first quarter of 202218  18 
Cash payments(84) (84)
Adjustments(9) (9)
Accrued restructuring action balances as of June 30, 2022$12 $ $12 
Remaining activities related to this restructuring were largely completed in the third quarter of 2022.
2022 Restructuring Actions:
Divestiture-Related Restructuring
During the third quarter of 2022, following the Food Safety Division split-off transaction and combination with Neogen completed in September 2022 (see Note 3) management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business.
These actions affected approximately 850 positions worldwide and resulted in a third quarter 2022 pre-tax charge of $41 million, within Corporate and Unallocated. The divestiture-related restructuring actions were recorded in the income statement as follows:
(Millions)2022
Cost of sales$3
Selling, general and administrative expenses36
Research, development and related expenses2
Total operating income impact$41
Divestiture-related restructuring actions, including cash impacts, follow:
(Millions)Employee-Related
Expense incurred in the third quarter of 202241 
Cash payments(31)
Accrued restructuring action balances as of December 31, 2022
$10 
Remaining activities related to this divestiture-related restructuring are expected to be largely completed through the first half of 2023.
2020 Restructuring Actions:
Divestiture-Related Restructuring
During the second quarter of 2020, following the divestiture of substantially all of the drug delivery business (see Note 3) management approved and committed to undertake certain restructuring actions addressing corporate functional costs and manufacturing footprint across 3M in relation to the magnitude of amounts previously allocated/burdened to the divested business. These actions affected approximately 1,300 positions worldwide and resulted in a second quarter 2020 pre-tax charge of $55 million, within Corporate and Unallocated. The divestiture-related restructuring actions were recorded in the income statement as follows:
(Millions)2020
Cost of sales$42 
Selling, general and administrative expenses12 
Research, development and related expenses
Total operating income impact$55 
Divestiture-related restructuring actions, including cash and non-cash impacts, follow:
(Millions)Employee-RelatedAsset-Related and OtherTotal
Expense incurred in the second quarter of 2020$32 $23 $55 
Non-cash changes— (14)(14)
Cash payments(14)— (14)
Adjustments(3)— (3)
Accrued restructuring action balance as of December 31, 202015 24 
Cash Payments(5)— (5)
Adjustments(1)— (1)
Accrued restructuring action balance as of June 30, 2021$$$18 
Remaining activities related to this divestiture-related restructuring were largely completed in the third quarter of 2021.
Other Restructuring
Additionally, in the second quarter of 2020, management approved and committed to undertake certain restructuring actions addressing structural enterprise costs and operations in certain end markets as a result of the COVID-19 pandemic and related economic impacts. These actions affected approximately 400 positions worldwide and resulted in a second quarter 2020 pre-tax charge of $58 million. The restructuring charges were recorded in the income statement as follows:
(Millions)2020
Cost of sales$13 
Selling, general and administrative expenses37 
Research, development and related expenses
Total operating income impact$58 
The business segment operating income impact of these restructuring charges is summarized as follows:
2020
(Millions)
Employee-RelatedAsset-Related and OtherTotal
Safety and Industrial$$— $
Transportation and Electronics11 — 11 
Health Care12 — 12 
Consumer— 
Corporate and Unallocated— 23 23 
Total Operating Expense$35 $23 $58 
Restructuring actions, including cash and non-cash impacts, follow:
(Millions)Employee-RelatedAsset-RelatedTotal
Expense incurred in the second quarter of 2020$35 $23 $58 
Non-cash changes— (23)(23)
Cash payments(2)— (2)
Adjustments(9)— (9)
Accrued restructuring action balances as of December 31, 202024 — 24 
Cash Payments(4)— (4)
Adjustments(9)— (9)
Accrued restructuring action balances as of March 31, 2021$11 $— $11 
Remaining activities related to this restructuring were largely completed in the second quarter of 2021.